Prodotti competitors / Area Oncology
NICE advice and quality standards: Interventional procedures guidance - Nivolumab with chemotherapy for neoadjuvant treatment of resectable non-small-cell lung cancer
![Immagine News](/media/l4el5htd/cat-2.jpg?anchor=center&mode=crop&width=722&height=442)
NICE (National Institute for Health and Care Excellence) pubblished on 22 March 2023 the Interventional procedures guidance on Nivolumab:
Nivolumab with chemotherapy for neoadjuvant treatment of resectable non-small-cell lung cancer. full guidance available here
Grazie per il tuo feedback!